Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sumel Ashique

Showing results (81-90 of 141) with videos related to

Pageof 15
Sort By:
European Journal of Pharmacology|August 18, 2024
Unlocking the possibilities of therapeutic potential of silymarin and silibinin against neurodegenerative Diseases-A mechanistic overviewSumel Ashique, Sourav Mohanto, Nitish Kumar, et al.
Current Pharmaceutical Design|October 15, 2025
Cataract Management in the Modern Era: Therapeutic Advances and Unmet NeedsSumit Durgapal, Prashant Kumar, Bhakti Sudha Pandey, et al.
Tissue & Cell|October 11, 2025
Exosome as emerging therapeutic platform for wound healing: Current status, advancement and future crosstalkSumel Ashique, Ashish Garg, Anas Islam, et al.
Current Pharmaceutical Design|August 15, 2025
Neuro-protective Potential of Honey: A Narrative ReviewSumel Ashique, Anas Islam, Prashant Kumar, et al.
Molecular Biology Reports|January 21, 2025
Exploring extracellular RNA as drivers of chemotherapy resistance in cancerYumna Khan, Md Sadique Hussain, Prasanna Srinivasan Ramalingam, et al.
The American Journal of Medicine|March 14, 2024
A Critical Review on the Long-Term COVID-19 Impacts on Patients With DiabetesSumel Ashique, Neeraj Mishra, Ashish Garg, et al.
Future Medicinal Chemistry|July 16, 2025
Epigenetic therapy meets targeted protein degradation: HDAC-PROTACs in cancer treatmentMd Sadique Hussain, Liming Zhang, Amita Joshi Rana, et al.
Bioorganic Chemistry|May 12, 2026
Oxazole derivatives as promising kinase inhibitors: a new era in Cancer drug discoveryRajarshi Nath, Biplab Debnath, Indrajit Maity, et al.
Journal of Biochemical and Molecular Toxicology|November 10, 2025
ASK1 Signaling in Cancer: Pathogenic Driver or Therapeutic Target?Yumna Khan, Muhammad Afzal, Suhas Ballal, et al.
Current Pharmaceutical Biotechnology|September 15, 2025
Understanding Antimicrobial Resistance: From Mechanisms to Public Health ImplicationsKrishnendu Adhikary, Krishnendu Ganguly, Susmita Chakrabarty, et al.
Pageof 15

Showing results (81-90 of 141) with videos related to

Sort By:
Pageof 15
European Journal of Pharmacology|August 18, 2024
Unlocking the possibilities of therapeutic potential of silymarin and silibinin against neurodegenerative Diseases-A mechanistic overviewSumel Ashique, Sourav Mohanto, Nitish Kumar, et al.
Current Pharmaceutical Design|October 15, 2025
Cataract Management in the Modern Era: Therapeutic Advances and Unmet NeedsSumit Durgapal, Prashant Kumar, Bhakti Sudha Pandey, et al.
Tissue & Cell|October 11, 2025
Exosome as emerging therapeutic platform for wound healing: Current status, advancement and future crosstalkSumel Ashique, Ashish Garg, Anas Islam, et al.
Current Pharmaceutical Design|August 15, 2025
Neuro-protective Potential of Honey: A Narrative ReviewSumel Ashique, Anas Islam, Prashant Kumar, et al.
Molecular Biology Reports|January 21, 2025
Exploring extracellular RNA as drivers of chemotherapy resistance in cancerYumna Khan, Md Sadique Hussain, Prasanna Srinivasan Ramalingam, et al.
The American Journal of Medicine|March 14, 2024
A Critical Review on the Long-Term COVID-19 Impacts on Patients With DiabetesSumel Ashique, Neeraj Mishra, Ashish Garg, et al.
Future Medicinal Chemistry|July 16, 2025
Epigenetic therapy meets targeted protein degradation: HDAC-PROTACs in cancer treatmentMd Sadique Hussain, Liming Zhang, Amita Joshi Rana, et al.
Bioorganic Chemistry|May 12, 2026
Oxazole derivatives as promising kinase inhibitors: a new era in Cancer drug discoveryRajarshi Nath, Biplab Debnath, Indrajit Maity, et al.
Journal of Biochemical and Molecular Toxicology|November 10, 2025
ASK1 Signaling in Cancer: Pathogenic Driver or Therapeutic Target?Yumna Khan, Muhammad Afzal, Suhas Ballal, et al.
Current Pharmaceutical Biotechnology|September 15, 2025
Understanding Antimicrobial Resistance: From Mechanisms to Public Health ImplicationsKrishnendu Adhikary, Krishnendu Ganguly, Susmita Chakrabarty, et al.
Pageof 15